Skip to main content
Premium Trial:

Request an Annual Quote

Eli Lilly Takes Perpetual License to Entelos' DrugMatrix Database

NEW YORK (GenomeWeb News) – Entelos said today that Eli Lilly has purchased a perpetual license to its DrugMatrix toxicogenomics database.
Under the terms of the agreement, Lilly will make a one-time payment to Entelos for a perpetual license to the database and customized report services from the company’s ToxFx business, with the option for continued support.
Financial terms were not disclosed.
Entelos, a biosimulation firm that develops "virtual humans" to help predict drug response, picked up the DrugMatrix database in its acquisition of Iconix last August.
The database is a reference set of gene expression profiles for benchmark drugs and compounds that are linked to pharmacology, toxicology, and clinical pathology measurements. It currently includes profiles from more than 630 different compounds.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.